Parallel Advisors’s Mesa Laboratories MLAB Stock Holding History

Parallel Advisors’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.69K	Hold	27	–	–	﹤0.01%	3443
2026 Q1	$2.39K	Buy	+27	New	+$2.33K	﹤0.01%	3309
2024 Q1	–	Sell	-16	Closed	-$1.68K	–	3382
2023 Q4	$1.68K	Buy	16 +14	+700%	+$1.36K	﹤0.01%	2847
2023 Q3	$210	Hold	2	–	–	﹤0.01%	3227
2023 Q2	$257	Hold	2	–	–	﹤0.01%	3212
2023 Q1	$349	Hold	2	–	–	﹤0.01%	3212
2022 Q4	$332	Buy	+2	New	+$313	﹤0.01%	3108
2022 Q3	–	Sell	-22	Closed	-$4K	–	3362
2022 Q2	$4K	Sell	22 -13	-37%	-$2.85K	﹤0.01%	2359
2022 Q1	$9K	Sell	35 -16	-31%	-$4.34K	﹤0.01%	2073
2021 Q4	$17K	Sell	51 -2	-4%	-$628	﹤0.01%	1866
2021 Q3	$16K	Buy	53 +13	+33%	+$3.69K	﹤0.01%	1848
2021 Q2	$11K	Sell	40 -8	-17%	-$2.03K	﹤0.01%	1968
2021 Q1	$12K	Buy	48 +4	+9%	+$1.1K	﹤0.01%	1844
2020 Q4	$13K	Hold	44	–	–	﹤0.01%	1676
2020 Q3	$11K	Hold	44	–	–	﹤0.01%	1694
2020 Q2	$9K	Buy	44 +13	+42%	+$3K	﹤0.01%	1759
2020 Q1	$7K	Buy	+31	New	+$7.65K	﹤0.01%	1778

Other funds holding MLAB

LPP

Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Parallel Advisors's MLAB Position: Q2 2026 in Review

Parallel Advisors held its Mesa Laboratories (MLAB) position steady in Q2 2026 at 27 shares worth $2.69K. The position accounts for ﹤0.01% of the portfolio, ranked #3443.

Parallel Advisors first reported a position in MLAB in Q1 2020 and has held it in 17 quarters since. The position peaked at $17K in Q4 2021. 159 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

Parallel Advisors held 27 shares of Mesa Laboratories worth $2.69K as of Q2 2026.
Parallel Advisors left its Mesa Laboratories share count unchanged in Q2 2026.
Mesa Laboratories made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3443 holding.
Parallel Advisors first reported a position in Mesa Laboratories in Q1 2020 and has held it in 17 quarters since.
Parallel Advisors's Mesa Laboratories position peaked at $17K in Q4 2021.
159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.